The estimated Net Worth of Hans Peter Guler is at least $14.2 Million dollars as of 8 October 2004. Hans Guler owns over 31,000 units of Regeneron Pharmaceuticals stock worth over $13,875,466 and over the last 21 years Hans sold REGN stock worth over $297,000.
Hans has made over 2 trades of the Regeneron Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Hans exercised 31,000 units of REGN stock worth $230,020 on 8 October 2004.
The largest trade Hans's ever made was exercising 31,000 units of Regeneron Pharmaceuticals stock on 8 October 2004 worth over $230,020. On average, Hans trades about 17,667 units every 52 days since 2003. As of 8 October 2004 Hans still owns at least 12,156 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Hans Guler stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis, and Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: